336 related articles for article (PubMed ID: 25685910)
41. 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).
Bursavich MG; Parker DP; Willardsen JA; Gao ZH; Davis T; Ostanin K; Robinson R; Peterson A; Cimbora DM; Zhu JF; Richards B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1677-9. PubMed ID: 20137940
[TBL] [Abstract][Full Text] [Related]
42. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis.
Meyer H; Weihl CC
J Cell Sci; 2014 Sep; 127(Pt 18):3877-83. PubMed ID: 25146396
[TBL] [Abstract][Full Text] [Related]
43. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.
Hänzelmann P; Schindelin H
J Biol Chem; 2011 Nov; 286(44):38679-38690. PubMed ID: 21914798
[TBL] [Abstract][Full Text] [Related]
44. TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching.
Ye Q; Rosenberg SC; Moeller A; Speir JA; Su TY; Corbett KD
Elife; 2015 Apr; 4():. PubMed ID: 25918846
[TBL] [Abstract][Full Text] [Related]
45. Heteromeric p97/p97R155C complexes induce dominant negative changes in wild-type and autophagy 9-deficient Dictyostelium strains.
Arhzaouy K; Strucksberg KH; Tung SM; Tangavelou K; Stumpf M; Faix J; Schröder R; Clemen CS; Eichinger L
PLoS One; 2012; 7(10):e46879. PubMed ID: 23056506
[TBL] [Abstract][Full Text] [Related]
46. The ubiquitin-selective chaperone CDC-48/p97, a new player in DNA replication.
Deichsel A; Mouysset J; Hoppe T
Cell Cycle; 2009 Jan; 8(2):185-90. PubMed ID: 19158489
[TBL] [Abstract][Full Text] [Related]
47. Proteasome inhibitors: structure and function.
Nunes AT; Annunziata CM
Semin Oncol; 2017 Dec; 44(6):377-380. PubMed ID: 29935898
[TBL] [Abstract][Full Text] [Related]
48. Control of p97 function by cofactor binding.
Buchberger A; Schindelin H; Hänzelmann P
FEBS Lett; 2015 Sep; 589(19 Pt A):2578-89. PubMed ID: 26320413
[TBL] [Abstract][Full Text] [Related]
49. The general definition of the p97/valosin-containing protein (VCP)-interacting motif (VIM) delineates a new family of p97 cofactors.
Stapf C; Cartwright E; Bycroft M; Hofmann K; Buchberger A
J Biol Chem; 2011 Nov; 286(44):38670-38678. PubMed ID: 21896481
[TBL] [Abstract][Full Text] [Related]
50. Development of p97 AAA ATPase inhibitors.
Chou TF; Deshaies RJ
Autophagy; 2011 Sep; 7(9):1091-2. PubMed ID: 21606684
[TBL] [Abstract][Full Text] [Related]
51. UV-induced proteolysis of RNA polymerase II is mediated by VCP/p97 segregase and timely orchestration by Cockayne syndrome B protein.
He J; Zhu Q; Wani G; Wani AA
Oncotarget; 2017 Feb; 8(7):11004-11019. PubMed ID: 28036256
[TBL] [Abstract][Full Text] [Related]
52. Arsenic Compromises Both p97 and Proteasome Functions.
Tillotson J; Zerio CJ; Harder B; Ambrose AJ; Jung KS; Kang M; Zhang DD; Chapman E
Chem Res Toxicol; 2017 Jul; 30(7):1508-1514. PubMed ID: 28636814
[TBL] [Abstract][Full Text] [Related]
53. The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97.
Trusch F; Matena A; Vuk M; Koerver L; Knævelsrud H; Freemont PS; Meyer H; Bayer P
J Biol Chem; 2015 Dec; 290(49):29414-27. PubMed ID: 26475856
[TBL] [Abstract][Full Text] [Related]
54. Inhibitors of the ATPase p97/VCP: From basic research to clinical applications.
Kilgas S; Ramadan K
Cell Chem Biol; 2023 Jan; 30(1):3-21. PubMed ID: 36640759
[TBL] [Abstract][Full Text] [Related]
55. The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97.
Bertram C; von Neuhoff N; Skawran B; Steinemann D; Schlegelberger B; Hass R
BMC Cell Biol; 2008 Feb; 9():12. PubMed ID: 18279508
[TBL] [Abstract][Full Text] [Related]
56. COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.
Cayli S; Klug J; Chapiro J; Fröhlich S; Krasteva G; Orel L; Meinhardt A
J Biol Chem; 2009 Dec; 284(50):34944-53. PubMed ID: 19826004
[TBL] [Abstract][Full Text] [Related]
57. Valosin-containing Protein (VCP)/p97 Segregase Mediates Proteolytic Processing of Cockayne Syndrome Group B (CSB) in Damaged Chromatin.
He J; Zhu Q; Wani G; Sharma N; Wani AA
J Biol Chem; 2016 Apr; 291(14):7396-408. PubMed ID: 26826127
[TBL] [Abstract][Full Text] [Related]
58. Structural basis for ovarian tumor domain-containing protein 1 (OTU1) binding to p97/valosin-containing protein (VCP).
Kim SJ; Cho J; Song EJ; Kim SJ; Kim HM; Lee KE; Suh SW; Kim EE
J Biol Chem; 2014 May; 289(18):12264-74. PubMed ID: 24610782
[TBL] [Abstract][Full Text] [Related]
59. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.
Kuhn DJ; Chen Q; Voorhees PM; Strader JS; Shenk KD; Sun CM; Demo SD; Bennett MK; van Leeuwen FW; Chanan-Khan AA; Orlowski RZ
Blood; 2007 Nov; 110(9):3281-90. PubMed ID: 17591945
[TBL] [Abstract][Full Text] [Related]
60. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
Lan B; Chai S; Wang P; Wang K
Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
